Skip to main content

NHS: Drugs

Question for Department of Health

UIN 9348, tabled on 8 September 2015

To ask the Secretary of State for Health, whether NHS England has had discussions with NICE on the assessment of medicines in specialised commissioning.

Answered on

16 September 2015

In June 2015, NHS England published its response to its consultation, Investing in Specialised Services. This is available at:

www.england.nhs.uk/commissioning/wp-content/uploads/sites/12/2015/06/nhse-respns-publictn-17-06-15.pdf

In it, NHS England stated that it had agreed with the National Institute for Health and Care Excellence (NICE) that both organisations should jointly explore the extent to which NICE may play a role in delivering clinical evidence reviews as part of the process for assessing proposed new investments in future years. This was in response to submissions received during the consultation, calling for the process of reviewing the clinical evidence for proposed new investments in specialised services to be led by NICE.

NHS England has advised that no decisions in this regard have yet been made. Preliminary discussions across the two organisations are expected to commence this month.